PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
07-Oct-2024 Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024 Transgene
07-Oct-2024 Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth Galapagos NV
07-Oct-2024 Major Shareholder Announcement Genmab A/S
07-Oct-2024 Nouscom to Present Updated Positive Data on NOUS-209’s Potential to ‘Intercept’ Cancer in Lynch Syndrome Carriers at SITC 2024 Nouscom
07-Oct-2024 Researchers develop way to selectively target diseased cells in motor neurone disease The Francis Crick Institute
04-Oct-2024 AI-Powered Protocol Generation: A New Era in Clinical Trials clinion
04-Oct-2024 Tower Launches Customer Sustainability Hub with Practical Tools for Lower-Impact Pharmaceutical Cold Chain Tower Cold Chain
03-Oct-2024 MitoRx Therapeutics Strengthens Leadership with Key Appointments as it Reveals Obesity Programme MitoRx Therapeutics
03-Oct-2024 White City Place signs landmark tenant Imperial College London, continuing rapid growth as part of leading UK life sciences and technology district Stanhope
03-Oct-2024 Lundbeck initiates clinical trial in immunology for Lu AG22515 in Thyroid Eye Disease H. Lundbeck A/S
03-Oct-2024 Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens® Enara Bio
03-Oct-2024 ProductLife Group (PLG) Acquires Nextep to Further Expand its Global Patient Access Capabilities ProductLife Group
03-Oct-2024 MitoRx Therapeutics Strengthens Leadership with Key Appointments as it Reveals Obesity Programme MitoRx Therapeutics
03-Oct-2024 Xcell Biosciences Expands AmplifyBio Collaboration with Unique Cell and Gene Therapy Manufacturing Capabilities Xcell Biosciences
03-Oct-2024 Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers Tessellate BIO
03-Oct-2024 Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient Heidelberg Pharma
03-Oct-2024 First Clinical Data on Ornithine Transcarbamylase Deficiency Program to be presented at the European Society of Gene & Cell Therapy 31st Annual Meeting 2024 Bloomsbury Genetic Therapies Limited
01-Oct-2024 New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks Pharmanovia
01-Oct-2024 Galapagos receives transparency notification from EcoR1 Capital Galapagos
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm